Thioguanine nucleotides and thiopurine methyltransferase in immunobullous diseases: optimal levels as adjunctive tools for azathioprine monitoring

Archives of Dermatology

Volumn 145, Issue 6, 2009, Pages 644-652

  El Azhary, Rokea A ^a   Farmer, Sara A ^a   Drage, Lisa A ^a   Rogers III, Roy S ^a   McEvoy, Marian T ^a   Davis, Mark D P ^a   Bridges, Alina G ^a   Gibson, Lawrence E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DRUG METABOLITE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE;

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG ERYTHROCYTE LEVEL; DRUG METABOLISM; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MAXIMUM TOLERATED DOSE; METHYLTRANSFERASES; MIDDLE AGED; PEMPHIGUS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THIOGUANINE; TREATMENT OUTCOME;

EID: 67449138845     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.81     Document Type: Article

References (35)

1. Schwartz RS. Immunosuppression: back to the future. World J Surg. 2000;24(7):783-786.
2. El-Azhary RA. Azathioprine: current status and future considerations. Int J Dermatol. 2003;42(5):335-341.
3. Lepage GA. Basic biochemical effects and mechanism of action of 6-thioguanine. Cancer Res. 1963;23:1202-1206.
4. Elion GB. The George Hitchings and Gertrude Elion lecture: the pharmacology of azathioprine. Ann N Y Acad Sci. 1993;685:400-407.
5. Quéméneur L, Gerland LM, Flacher M, Ffrench M, Revillard JP, Genestier L. Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. J Immunol. 2003;170(10):4986-4995. (Pubitemid 36554728)
6. + T lymphocytes. J Clin Invest. 2003;111(8):1133-1145.
7. Zimm S, Collins JM, Riccardi R, et al. Variable bioavailability of oral mercaptopurine: is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983;308(17):1005-1009.
8. Van Os EC, Zins BJ, Sandborn WJ, et al. Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration. Gut. 1996;39(1):63-68. (Pubitemid 26239107)
9. Snow JL, Gibson LE. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients. Arch Dermatol. 1995;131(2):193-197.
10. Snow JL, Gibson LE. A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients. J Am Acad Dermatol. 1995;32(1):114-116.
11. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32(5):651-662. (Pubitemid 10061685)
12. Krynetski EY, Evans WE. Pharmacogenetics of cancer therapy: getting personal. Am J Hum Genet. 1998;63(1):11-16. (Pubitemid 30428311)
13. Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst. 1999;91(23):2001-2008.
14. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118(4):705-713. (Pubitemid 30171620)
15. Pike MG, Franklin CL, Mays DC, Lipsky JJ, Lowry PW, Sandborn WJ. Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood. J Chromatogr B Biomed Sci Appl. 2001;757(1):1-9. (Pubitemid 32424452)
16. Bergan S, Rugstad HE, Bentdal O, et al. Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation. Transplantation. 1998;66(3):334-339. (Pubitemid 28390215)
17. Bergan S. Optimisation of azathioprine immunosuppression after organ transplantation by pharmacological measurements. BioDrugs. 1997;8(6):446-456. (Pubitemid 27517611)
18. Turgeon CT, Lacey JM, Magera MJ, et al. Determination of thiopurine methyltransferase activity in red blood cells (RBC) by tandem mass spectrometry [abstract MP 222]. J Am Soc Mass Spectrom. 2007;18(5):34S.
19. Dervieux T, Boulieu R. Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC. Clin Chem. 1998;44(3):551-555. (Pubitemid 28141350)
20. Derijks LJ, Gilissen LP, Engels LG, et al. Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy. Ther Drug Monit. 2004;26(3):311-318. (Pubitemid 38703020)
21. Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord. 2003; 3(suppl 1):S30-S38. (Pubitemid 36395165)
22. Maddocks JL, Lennard L, Amess J, Amos R, Thomas RM. Azathioprine and severe bone marrow depression. Lancet. 1986;1(8473):156.
23. Goldenberg BA, Rawsthorne P, Bernstein CN. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease. Am J Gastroenterol. 2004;99(9):1744-1748. (Pubitemid 39237503)
24. Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006;130(4):1047-1053.
25. Schedel J, Godde A, Schutz E, et al. Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases. Ann N Y Acad Sci. 2006;1069:477-491. (Pubitemid 43989892)
26. Reuther LO, Sonne J, Larsen NE, et al. Pharmacological monitoring of azathioprine therapy. Scand J Gastroenterol. 2003;38(9):972-977. (Pubitemid 37153627)
27. Dervieux T, Medard Y, Baudouin V, et al. Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine. Br J Clin Pharmacol. 1999;48(6):793-800.
28. Decaux G, Horsmans Y, Houssiau F, Desager JP. High 6-thioguanine nucleotide levels and low thiopurine methyltransferase activity in patients with lupus erythematosus treated with azathioprine. Am J Ther. 2001;8(3):147-150. (Pubitemid 33753110)
29. Lowry PW, Franklin CL, Weaver AL, et al. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut. 2001;49(5):665-670. (Pubitemid 32989203)
30. Belaiche J, Desager JP, Horsmans Y, Louis E. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand J Gastroenterol. 2001;36(1):71-76. (Pubitemid 32147184)
31. Gearry RB, Barclay ML, Roberts RL, et al. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Intern Med J. 2005;35(10):580-585. (Pubitemid 41564403)
32. Gardiner SJ, Begg EJ, Barclay ML, Kirkpatrick CM. Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine. Adverse Drug React Toxicol Rev. 2000;19(4):293-312. (Pubitemid 32117719)
33. Colletti RB. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway. J Pediatr Gastroenterol Nutr. 2006;43(3):282-283. (Pubitemid 44368180)
34. Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut. 2001;48(5):642-646. (Pubitemid 32378583)
35. Banerjee S, Bishop WP. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center. J Pediatr Gastroenterol Nutr. 2006;43(3):324-330. (Pubitemid 44368187)